ES2148283T3 - Gen merlin supresor de tumores y usos del mismo. - Google Patents

Gen merlin supresor de tumores y usos del mismo.

Info

Publication number
ES2148283T3
ES2148283T3 ES94301367T ES94301367T ES2148283T3 ES 2148283 T3 ES2148283 T3 ES 2148283T3 ES 94301367 T ES94301367 T ES 94301367T ES 94301367 T ES94301367 T ES 94301367T ES 2148283 T3 ES2148283 T3 ES 2148283T3
Authority
ES
Spain
Prior art keywords
merlin
gen
same
tumor suppressor
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94301367T
Other languages
English (en)
Inventor
James A Trofatter
Mia M Maccollin
James F Gusella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of ES2148283T3 publication Critical patent/ES2148283T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UNA NUEVA PROTEINA SUPRESORA DE TUMORES, MERLIN , QUE COMPRENDE SECUENCIAS DE ADN QUE CODIFICAN MERLIN, VECTORES RECOMBINANTES Y HUESPEDES CAPACES DE EXPRESAR MERLIN. SE PREVEN TAMBIEN EL METODO PARA EL DIAGNOSTICO Y TRATAMIENTO DE TUMORES ASOCIADOS A MERLIN, Y PARA EL DIAGNOSTICO Y TRATAMIENTO DE LA ENFERMEDAD NEUROFIBROMATOSIS 2(NF2).
ES94301367T 1993-02-25 1994-02-25 Gen merlin supresor de tumores y usos del mismo. Expired - Lifetime ES2148283T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2203493A 1993-02-25 1993-02-25
US2606393A 1993-03-04 1993-03-04
US10880893A 1993-08-19 1993-08-19
US08/171,718 US5707863A (en) 1993-02-25 1993-12-22 Tumor suppressor gene merlin

Publications (1)

Publication Number Publication Date
ES2148283T3 true ES2148283T3 (es) 2000-10-16

Family

ID=27487063

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94301367T Expired - Lifetime ES2148283T3 (es) 1993-02-25 1994-02-25 Gen merlin supresor de tumores y usos del mismo.

Country Status (10)

Country Link
US (2) US5707863A (es)
EP (1) EP0613945B1 (es)
JP (1) JPH07143884A (es)
AT (1) ATE192489T1 (es)
CA (1) CA2115404A1 (es)
DE (1) DE69424209T2 (es)
DK (1) DK0613945T3 (es)
ES (1) ES2148283T3 (es)
GR (1) GR3034057T3 (es)
PT (1) PT613945E (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578462A (en) * 1994-01-10 1996-11-26 Bristol-Myers Squibb Company NF2 isoforms
AU2456397A (en) * 1996-04-12 1997-11-07 Muro Pharmaceutical, Inc. Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof
GB9812674D0 (en) * 1998-06-12 1998-08-12 Central Manchester Healthcare Nucleic acids
US7053200B1 (en) 1999-06-01 2006-05-30 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
JP2003530817A (ja) 1999-06-01 2003-10-21 ベイラー カレッジ オブ メディスン 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法
WO2001009318A1 (fr) * 1999-07-29 2001-02-08 Helix Research Institute Genes associes au cancer du foie
CA2398683A1 (en) * 2000-01-20 2001-07-26 Genome Therapeutics Corporation Rapid determination of gene structure using cdna sequence
ATE375404T1 (de) * 2000-06-27 2007-10-15 Von Recklinghausen Ges E V Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose
US20040014699A1 (en) * 2002-07-18 2004-01-22 Isis Pharmaceuticals, Inc. Antisense modulation of PTPRM expression
US20040249023A1 (en) * 2003-01-17 2004-12-09 Stoffer James O. Compounds for corrosion resistant primer coatings and protection of metal substrates
JP6238900B2 (ja) 2011-10-28 2017-11-29 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｎａｅ阻害物質に対する応答のバイオマーカー
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體
CN110846309B (zh) * 2018-08-20 2023-03-24 中国农业科学院兰州兽医研究所 用于鉴定多房棘球绦虫引物对、引物探针组以及他们的应用
CA3216712A1 (en) * 2021-04-14 2022-10-20 Research Institute At Nationwide Children's Hospital Materials and methods for neurofibromin 2/merlin (nf2) gene therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04503306A (ja) * 1989-02-01 1992-06-18 ザ・ジェネラル・ホスピタル・コーポレーション 単純ヘルペスウイルス１型発現ベクター
AU2468992A (en) * 1991-08-16 1993-03-16 General Hospital Corporation, The Method of gene delivery to post-mitotic cells
US5578462A (en) * 1994-01-10 1996-11-26 Bristol-Myers Squibb Company NF2 isoforms

Also Published As

Publication number Publication date
CA2115404A1 (en) 1994-08-26
EP0613945A2 (en) 1994-09-07
US6077685A (en) 2000-06-20
PT613945E (pt) 2000-10-31
DE69424209D1 (de) 2000-06-08
EP0613945A3 (en) 1996-01-17
US5707863A (en) 1998-01-13
DE69424209T2 (de) 2001-01-25
EP0613945B1 (en) 2000-05-03
JPH07143884A (ja) 1995-06-06
ATE192489T1 (de) 2000-05-15
DK0613945T3 (da) 2000-09-25
GR3034057T3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
ES2061527T3 (es) Proteina precursora del polipeptido apc, el correspondiente dna codificador y el uso para diagnosticar del dna y de la proteina.
ES2148283T3 (es) Gen merlin supresor de tumores y usos del mismo.
ATE449851T1 (de) Menschlicher telomerase reverse transcriptase promoter
DE3856180D1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
NL300140I2 (nl) Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
ATE11372T1 (de) Von vernetztem fibrin abgeleitete radiomarkierte peptide zur bestimmung von thrombi und die dieselben enthaltenden injektierbaren zusammensetzungen.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
ATE184917T1 (de) Rekombinante methode und wirt zur herstellung von xylitol
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
EA199900941A1 (ru) БЕЛКИ, СВЯЗЫВАЮЩИЕСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ И КОДИРУЮЩИЕ ИХ ПОЛИНУКЛЕОТИДЫ
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ES2094972T3 (es) Procedimiento para obtencion de fosfatasa alcalina eucariotica recombinante, biologicamente activa.
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.
IT8720707A0 (it) Impiego del 2,4-monofurfuriliden-sorbitolo ad uso cosmetico.
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
IT1230433B (it) Agente e procedimento per la concia del cuoio
IT8241523A0 (it) Agente per la conciatura del cuoio e procedimento per la sua fabbricazione.
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide
ATE65394T1 (de) Behandlung von knochenschwund.
IT1230656B (it) Procedimento per la realizzazione di doposci e/o stivaletti e doposci e/o stivaletti ottenuti con detto procedimento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 613945

Country of ref document: ES